SIGNPATH PHARMA, INC. Proceeds from Issuance Initial Public Offering
SIGNPATH PHARMA, INC. reported Proceeds from Issuance Initial Public Offering of $319.49 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2016-04-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceInitialPublicOffering · last filed 2016-04-08
- SIGNPATH PHARMA, INC. proceeds from issuance initial public offering for fiscal 2015 was $319.49K, a 10.46% increase from fiscal 2014.
- SIGNPATH PHARMA, INC. proceeds from issuance initial public offering for fiscal 2014 was $289.24K.
| Period end | Proceeds from Issuance Initial Public Offering 12 month |
|---|---|
| 2015-12-31 | $319.49K 10-K · filed 2016-04-08 |
| 2014-12-31 | $289.24K 10-K · filed 2016-04-08 |